ID

24375

Descripción

NCT00079911 Study ID 100181 Clinical Study ID HS2100181 Study Title: An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons with CD4+ lymphocyte count <100 cells/mm3. Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00079911 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Terminated Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Genital Herpes; HIV infection

Palabras clave

Versiones (1)
  1. 30/7/17 30/7/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

30 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT NCT00079911

Inglés

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT NCT00079911

1 formularios  
Study administration
Descripción

Study administration

Subject Identifier
Descripción

Subject Identifier

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348585
INVESTIGATIONAL PRODUCT
Descripción

INVESTIGATIONAL PRODUCT

Investigational Product
Descripción

Check carefully for any overlapping start/stop date. Ensure any deviations from investigational product are recorded correctly as outlined in the study protocol. Record a new start and stop date if greater than or equal to one day of dosing is missed.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0304229
Start date
Descripción

pharmacotherapy start date

Tipo de datos

date

Unidades de medida
  • DD/MMM/YY
Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0808070
DD/MMM/YY
Stop date
Descripción

pharmacotherapy stop date

Tipo de datos

date

Unidades de medida
  • DD/MMM/YY
Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0806020
DD/MMM/YY
Volver a la parte superior de la página

Similar models

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT NCT00079911

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Study administration
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Item Group
INVESTIGATIONAL PRODUCT
Item
Investigational Product
integer
C0304229 (UMLS CUI [1])
Investigational Product
Code List
Investigational Product
CL Item
Double-Blind therapy (23)
CL Item
Open-label treatment (24)
pharmacotherapy start date
Item
Start date
date
C0013216 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
pharmacotherapy stop date
Item
Stop date
date
C0013216 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial